Skip to main content
Clinical Trials/CTRI/2024/03/063469
CTRI/2024/03/063469
Recruiting
未知

Delineating the genomic basis of neurodegeneration and mitochondrial disorders associated with defective DNA break repair - NI

Sanjiban Chakrabarty0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: G300- Alzheimers disease with early onsetHealth Condition 2: G309- Alzheimers disease, unspecifiedHealth Condition 3: G31- Other degenerative diseases of nervous system, not elsewhere classifiedHealth Condition 4: G328- Other specified degenerative disorders of nervous system in diseases classified elsewhere
Sponsor
Sanjiban Chakrabarty
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational

Investigators

Sponsor
Sanjiban Chakrabarty

Eligibility Criteria

Inclusion Criteria

  • 1\. Individuals with clinical features, radiological findings, and biochemical analysis suggestive of a mitochondrial disorder using Mitochondrial Disease Criteria(Score more than 5\).
  • 2\. Clinical presentation – Motor developmental delay, myopathy, dystonia, ataxia, seizures, exercise intolerance, spasticity, growth failure, hearing and vision impairment, cardiomyopathy, gastrointestinal issues.

Exclusion Criteria

  • 1\. Individuals having a score of less than 5 utilizing mitochondrial disease criteria(MDC) regardless of age of onset or presentation.
  • 2\. Participate with non\-genetic disorders, such as autoimmune or inflammatory infections, endocrine or hypoxic insults in the neonatal period, medications, or toxins exposure

Outcomes

Primary Outcomes

Not specified

Similar Trials